Painkiller trial raises questions for FDA, Pfizer

By Shannon Brownlee and Jeanne Lenzer

In February 2005, the U.S. Food and Drug Administration (FDA) called a three-day hearing to review the risks of three painkillers known as C

Excerpts from this story referencing "Bextra":

"… . The advisory panel considered whether the other two COX-2s, Celebrex and Bextra, might also increase the risk of cardiovascular problems, including death, …"

"… are in the late 1990s. In November, 2001, Pfizer introduced a third COX-2, Bextra. These drugs, hailed as “super-aspirins” by the press, were invented i …"

"… ed Vioxx from the market, in September 2004, it appeared that Celebrex and Bextra also posed some of the same risks, and FDA was feeling mounting pressure t …"

"… t with stringent warnings and restrictions on its use? Should Celebrex and Bextra be permitted to remain on pharmacy shelves? How did the non-selective NSAI …"

FDA: A shell of its former self

By M. Asif Ismail

The Food and Drug Administration lacks the power to regulate pharmaceuticals and keep you safe

Excerpts from this story referencing "Bextra":

"… , were found to cause severe side effects. Merck's Vioxx and Pfizer's Bextra were withdrawn from the market. Celebrex was kept on the market, although …"

Drug industry influence timeline

What the pharmaceutical industry has gotten on its political investment

Excerpts from this story referencing "Bextra":

"… comes amidst heavily publicized safety concerns from painkillers Vioxx and Bextra, both of which were removed from the market in 2005.2005The pharmaceutical …"